Steven D Gore
Yale University
H-index: 70
North America-United States
Top articles of Steven D Gore
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute … | Annals of Hematology | Jan Philipp Bewersdorf Rory M Shallis Elad Sharon Silvia Park Rahul Ramaswamy | 2024/1 |
PD-1H/VISTA mediates immune evasion in acute myeloid leukemia | The Journal of clinical investigation | Tae Kon Kim Xue Han Qianni Hu Esten N Vandsemb Carly M Fielder | 2024/2/1 |
Equitable access to Clinical trials: how Do we achieve it? | American Society of Clinical Oncology Educational Book | Ana Acuña-Villaorduña Joaquina Celebre Baranda Jessica Boehmer Lola Fashoyin-Aje Steven D Gore | 2023/5 |
Expanding access to early phase trials: the CATCH-UP. 2020 experience | JNCI Cancer Spectrum | Joaquina C Baranda Francisco J Diaz Larry Rubinstein Anthony F Shields Farshid Dayyani | 2023/2/1 |
P745: MULTI-CENTER PHASE IB TRIAL OF THE HISTONE DEACTYLASE INHIBITOR ENTINOSTAT+ PEMBROLIZUMAB IN MYELODYSPLASTIC SYNDROME OR ACUTE MYELOID LEUKEMIA REFRACTORY TO … | HemaSphere | Jan Bewersdorf Rory M Shallis Elad Sharon Anne Caldwell Wei Wei | 2023/8/1 |
CTNI-53. ESTABLISHING A PHASE I AND RANDOMIZED PHASE II TRIAL OF SELINEXOR AND TEMOZOLOMIDE IN GLIOBLASTOMA | Neuro-oncology (Charlottesville, Va.) | Frances Chow Michael Berens Sharon Tamir Yosef Landesman Christopher Walker | 2023/11/10 |
421 A Phase 1 and Randomized Phase 2 Clinical Trial of Selinexor and Temozolomide in Recurrent Glioblastoma Among Adults: The Product of a Successful Team Science Approach | Journal of Clinical and Translational Science | Frances Chow Michael Berens Sharon Tamir Yosef Landesman Christopher Walker | 2023/4 |
Berzosertib plus topotecan vs topotecan alone in patients with relapsed small cell lung cancer: a randomized clinical trial | JAMA oncology | Nobuyuki Takahashi Zhonglin Hao Liza C Villaruz Jun Zhang Jimmy Ruiz | 2023/12/1 |
Abstract LB_A10: Efficacy of ATR inhibitor berzosertib plus topotecan or topotecan alone in patients with relapsed small cell lung cancer: A randomized clinical trial | NaN | Nobuyuki Takahashi Zhonglin Hao Liza C Villaruz Jun Zhang Jimmy Ruiz | 2023 |
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study | Blood Advances | Gregory A Abel Donnie Hebert Cecilia Lee Dana Rollison Nancy Gillis | 2023/7/25 |
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies | Blood advances | Edward J Gorak Michael Otterstatter Tareq Al Baghdadi Nancy Gillis James M Foran | 2023/10/24 |
Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea | Blood Advances | Rong Wang Rory M Shallis Jessica M Stempel Scott F Huntington Amer M Zeidan | 2023/3/14 |
Assessment of Outcomes of Consolidation Therapy By Number of Cycles of Blinatumomab Received in Newly Diagnosed Measurable Residual Disease Negative Patients with B-Lineage … | Blood | Selina M Luger Zhuoxin Sun Ryan J Mattison Elisabeth Paietta Kathryn G Roberts | 2023/11/28 |
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions | Blood Advances | Amy E DeZern Johannes B Goll R Coleman Lindsley Rafael Bejar Steffanie H Wilson | 2023/7/25 |
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the … | Jan Philipp Bewersdorf Zhuoer Xie Rafael Bejar Uma Borate Jacqueline Boultwood | 2023/3/11 | |
Vemurafenib and obinutuzumab as frontline therapy for hairy cell leukemia | NEJM evidence | Jae H Park Sean Devlin Benjamin H Durham Eric S Winer Scott Huntington | 2023/9/26 |
Correlation between Peripheral Blood and Bone Marrow Somatic Mutations Among Patients with Suspected or Established Myelodysplastic Syndromes from the National MDS Study | Blood | Amy E DeZern Johannes Goll Travis L Jensen Sridhar N Srivatsan Nancy K Gillis | 2023/11/28 |
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS | Blood advances | Maximilian Stahl Omar Abdel-Wahab Andrew H Wei Michael R Savona Mina L Xu | 2023/6/27 |
Phase Ia/Ib Study of BAY1895344 Plus Topoisomerase I Inhibitors with a Focus on Poorly Differentiated Neuroendocrine Carcinomas and Pancreatic Adenocarcinoma | Endocrine Abstracts | Shannon Stockton Ayers G Dan Michael Cecchini Raid Ajumaily Jennifer Whisenant | 2023/2/1 |
Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia | Cancer Medicine | Nikolai A Podoltsev Rong Wang Rory M Shallis Jessica M Stempel Mengyang Di | 2023/9 |
